Previous Article | Next Article ![]()
Journal of Bacteriology, January 2007, p. 160-168, Vol. 189, No. 1
0021-9193/07/$08.00+0 doi:10.1128/JB.01425-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
,
Center for Environmental Genomics, Department of Biology, McMaster University, 1280 Main Street West, Hamilton, Ontario, Canada L8S 4K1
Received 7 September 2006/ Accepted 17 October 2006
|
|
|---|
|
|
|---|
In N2-fixing bacteroids metabolizing C4-dicarboxylic acids via the TCA cycle, a pathway for the generation of acetyl coenzyme A (acetyl-CoA) is essential. One route for the formation of acetyl-CoA is via malic enzyme and pyruvate dehydrogenase (7, 8). Malic enzymes are responsible for the conversion of malate to pyruvate with the concomitant reduction of a nicotinamide cofactor. Sinorhizobium meliloti contains two malic enzymes, DME (diphosphopyridine nucleotide-dependent malic enzyme), which is dependent on NAD(P)+ (EC 1.1.1.39), and TME (triphosphopyridine nucleotide dependent malic enzyme), which utilizes NADP+ exclusively (EC 1.1.1.40) (39). S. meliloti dme mutants were shown to form root nodules which fail to fix nitrogen (7), while tme mutants formed wild-type nitrogen-fixing root nodules (7, 8). Biochemical characterization of DME and TME revealed that the enzymes have similar kinetic parameters and have almost identical Kms for substrate and cofactor, indicating that the enzymes should have similar rates of activity (39). The enzymes do differ in their responses to TCA cycle intermediates, with DME activity being enhanced by fumarate, succinate, and malate but inhibited by acetyl-CoA (9, 39).
Here we employed specific antibodies to directly quantify the levels of malic enzymes in free-living cells and bacteroids, and we found that TME protein levels in bacteroids are 20% of those in free-living cells. These data suggested that the reduced levels of TME in bacteroids could be the reason for its failure to functionally replace DME in dme mutant strains. We investigated this question by determining the symbiotic phenotypes of dme mutant strains carrying chromosomally integrated constructs in which (i) tme is expressed from the dme promoter and (ii) dme is expressed from the tme promoter.
The analysis of the symbiotic requirement for malic enzymes is complicated by the unusual bipartite structure of the DME and TME enzymes of S. meliloti. DME and TME are 770 and 761 amino acids in length, respectively, and are members of a large family of malic enzymes that contain an approximately 300-amino-acid domain at their C termini that is not present in other prokaryotic and eukaryotic malic enzymes, such as the 478- and 389-amino-acid enzymes from Bacillus stearothermophilus (19) and Streptococcus bovis (18), respectively (26). The C-terminal extension shows similarity to phosphotransacetylase enzymes (PTA) (EC 2.3.1.8) that are responsible for the interconversion of acetyl-CoA and acetyl phosphate. The widespread prevalence of the PTA-like domain suggests functional relevance; however, deletion of the C-terminal region of the S. meliloti malic enzymes did not abolish malic enzyme activity (26). We wished to determine if the C-terminal extension is required during symbiosis. To accomplish this task, two experimental procedures were carried out. First, the NAD+-dependent malic enzyme of Escherichia coli, SfcA (36), a protein that lacks the PTA-like extension, was expressed from the dme promoter in dme-deficient S. meliloti strains. Second, a truncated form of DME that lacks the C-terminal domain but still retains malic enzyme activity (26) was expressed in dme-deficient S. meliloti strains. Both constructs were analyzed in plant and enzyme assays in order to determine if either construct was able to support symbiotic nitrogen fixation.
|
|
|---|
Sp) (8) fail to grow on minimal medium with succinate as a carbon source. Complementation of this growth phenotype was used to determine whether the malic enzyme constructs created in this work were functional.
Derivatives of the gentamicin-resistant suicide vector pUCP30T (34) were mobilized into S. meliloti by triparental matings as previously described (11). Recombinants were selected on LBmc plates containing 20 µg/ml gentamicin (Gm) plus neomycin (Nm; 200 µg/ml), spectinomycin (Sp;100 µg/ml), or streptomycin (Sm; 200 µg/ml) as required. Because the pUCP30T chimeric malic enzyme constructs carried S. meliloti DNA from both the tme and dme gene regions, these constructs could recombine at either the tme or dme locus. To identify the cointegrate-recombination class, phage
M12 was used to transduce the Gm-resistant (Gmr) marker of pUCP30T and either the dme or tme mutation antibiotic resistance marker from individual recombinants into the wild-type strain Rm1021 (10). Approximately 30 clones from each transduction were replica plated onto LBmc plates containing neomycin (for the dme Tn5 mutations) or LBmc plates containing spectinomycin (for the tme
Sp mutation) and gentamicin (the antibiotic marker for pUCP30T). Cotransduction of both the Gmr and the dme or tme antibiotic resistance marker demonstrated linkage between pUCP30T and the demonstrated recombination at the particular locus of interest. In all cases, recombination at the targeted structural gene was achieved with the pUCP30T vector construct containing the same structural gene, and these strains were utilized for further experimentation. Crude cell extracts and bacteroid extracts were produced according to previous protocols (7, 12).
Molecular biology techniques and introduction of SphI sites into the dme and tme genes.
General molecular biology methodologies were performed according to standard techniques. To facilitate manipulation of the tme and dme genes of S. meliloti, an SphI site was inserted at the previously identified translational start sites with the primers 5'-GATACCCGGCATGCTTCCTCAACCTC-3' and 5'-CGCCCGTGTGCATGCCTTTGC-3', respectively, following the procedure of Kunkel et al. (22). The templates used for site-directed mutagenesis were produced from truncated regions of tme and dme. For dme, pTH139 containing the entire dme open reading frame was digested with SalI and religated to yield plasmid pTH398, containing 868 bp of the dme open reading frame. For tme, pTH251 (26) was digested with BspHI, end filled with Klenow polymerase, and digested with EcoRI. The resulting 480-bp fragment was gel purified and ligated into pUC119 digested with SphI, treated with Klenow polymerase, and redigested with EcoRI to produce pTH399. These plasmids were then transformed into E. coli strain CJ236 (ung dut) to generate single-stranded DNA (22). The resulting plasmids were transformed into DH5
cells and then screened for the presence of an SphI site. On average, 50% of the transformants contained the desired mutation. Following DNA sequencing to verify sequence integrity, the dme and tme constructs pTH400 and pTH401B, respectively, were used in further experiments. The full-length genes were reconstituted such that both genes would retain the SphI at the translational start site. dme was reconstructed by inserting the SalI fragment from pTH139 into pTH400 to produce pTH408. tme was reconstructed by inserting a 2.5-kb EcoRI fragment from pTH392 into pTH401B, resulting in pTH407B.
Production of the pdme-tme construct. To introduce tme downstream of the dme promoter, pTH408 was digested with SphI and KpnI, and the resulting 3.8-kb vector-dme promoter fragment was gel purified. Digesting pTH407B with SphI and KpnI and gel purifying the resulting 2.7-kb fragment isolated the tme structural gene. The two fragments were ligated to generate the plasmid pTH409. Transformants of E. coli EJ1321 carrying pTH409 grew on M9 minimal medium with succinate as the sole carbon source, verifying that pTH409 produced a functional TME product. To introduce the hybrid construct into S. meliloti, the 3.5-kb pdme-tme fragment was isolated with HindIII and KpnI and inserted into the similarly digested vector pUCP30T, to give pTH433. This cloning strategy resulted in the pdme-tme construct being inserted in the orientation opposite that of the lacZ promoter present on this plasmid, thus removing the possibility that a promoter other than dme could be responsible for expressing tme. Cointegration of pTH433 at the tme gene loci was verified by transduction.
Production of the ptme-dme construct. pTH407B was digested with HindIII and EcoRI, producing a 487-bp tme fragment that was inserted into pBluescript KS. A 2.98-kb dme fragment from pTH408 was isolated following digestion with HindIII and inserted into a similarly digested pBluescript KS vector. This resulted in the dme structural gene being inserted in the vector such that the BamHI site was in the 3' region of the gene. These two constructs allowed the use of the SphI site located in both fragments that were previously inserted into the translational start site of both genes. The final construct was produced by removing the 2.8-kb dme fragment via a SphI/BamHI digest followed by insertion downstream of the tme promoter in pBluescript KS, resulting in pTH596. This construct resulted in 471 bp of the tme promoter being positioned upstream of the dme open reading frame, with the translational start site of dme being fused to the translational start site of tme via the SphI site. The 3.3-kb hybrid construct was then digested with BamHI and KpnI and inserted into pUCP30T to create plasmid pTH597. A triparental mating was carried out to introduce the construct into various dme::Tn5 mutant S. meliloti strains, and transductions were carried out to verify recombination at the dme gene loci as described above.
Production of pdme-sfcA. The sfcA gene was amplified from the plasmid pMEE1 (36) using the primers 5'-GAA ACA GAG CAT GCA ACC AAA AAC AAA AAA AC-3' and 5'-CTC TCA TCC GCC AAA ACA GCC-3' (bold type indicates the SphI restriction site introduced in the PCR fragment at the translational start site of sfcA). The resulting 1.8-kb fragment was digested with SphI and PstI and ligated to the plasmid pTH408, which was similarly digested. This ligation replaced the dme structural gene of pTH408 with the sfcA gene in such a way that sfcA was positioned downstream of the dme promoter. The resulting plasmid, pTH512, was digested with HindIII and PstI, and the 2.1-kb fragment (pdme-sfcA) was inserted into pUCP30T, also digested with HindIII and PstI, to generate pTH513. Plasmid pTH513 complemented RmH194 for growth on succinate verifying that the pdme-sfcA construct was functional. pTH513 was introduced into several S. meliloti malic enzyme deficient mutants through triparental matings, and transductions were carried out to verify recombination at the dme gene locus.
Production of dme
c construct.
pTH139 (9) carrying the entire dme open reading frame was digested with PstI and religated to remove the C-terminal region of dme and leave only the first 449 amino acids of DME. The truncated dme gene (dme
c) was removed from the resulting plasmid (pTH452) via digestion with HindIII and XbaI and inserted into pUCP30T digested with the same enzymes to produce pTH458. A triparental mating was carried out to introduce the construct into dme::Tn5 mutant S. meliloti strains, and transductions were carried out to verify recombination at the dme gene loci as described above.
Enzyme assays and plant tests. For both free-living cells and bacteroid samples, pyruvate formation assays were carried out in the presence of either 1.5 mM NAD+ or NADP+ to determine DME or TME activity, respectively, as previously described (9). Malate dehydrogenase assays were utilized to verify cell and bacteroid extract integrity (9), with the change in absorption at 340 nm recorded with a Varian Cary 1E UV-visible spectrophotometer for approximately 3 to 5 min. Protein concentrations were determined using the Bio-Rad protein assay.
Plant assays with Medicago sativa var. Iroquois were carried out using Leonard assemblies following the method described by Yarosh et al. (42). Triplicate pots of 10 to 12 seedlings were grown, and 28 days postinoculation the plants were harvested. Acetylene reduction assays were carried out with three root systems per pot according to the method of Yarosh et al. (42), and the plants themselves were dried for 3 weeks, after which time the dry weights were recorded.
Native polyacrylamide gel electrophoresis (PAGE) and Western blots. Native polyacrylamide gels (7%) were produced as previously described (26). Portions of 30 µg per sample of crude cell or bacteroid extract were electrophoresed at 4°C with a constant current of 4 mA for 1 h and 7 mA thereafter until the dye front was 1 cm from the end of the gel. Following electrophoresis, the gels were rinsed and stained for NAD+-dependent malic enzyme activity as previously described (26).
Polyclonal antibodies were obtained by repeated injection of female specific-pathogen-free rabbits with 200 µg of purified DME or TME protein (39). Polyclonal antibodies produced in this way were specific for the respective antigen and reacted with denatured protein. Proteins were transferred from 7% sodium dodecyl sulfate (SDS)-polyacrylamide gels to Immobilon P membranes (Millipore) and treated with anti-TME or anti-DME antibody (a 1/10,000 dilution) for 60 min. The membranes were then exposed to the secondary antibody (anti-rabbit antibody-peroxidase; Sigma) for 30 min and developed using enhanced chemiluminescence reagent (Amersham).
Quantification of the malic enzymes. In order to quantify the DME and TME present in free-living cells and bacteroids, two Western blots for each protein were produced. S. meliloti cell extracts were obtained from an overnight LBmc-grown culture, while bacteroids were obtained from alfalfa plants inoculated with wild-type S. meliloti. Each SDS-PAGE gel had a constant amount of total free-living protein, with one gel containing various amounts of purified protein while the second had various amounts of total bacteroid protein. Two exposures (30 s and 1 min) were used for each Western blot, and a laser densitometer was used to measure the relative intensities of DME and TME. Two separate standard curves for the purified proteins were produced, and these were used to estimate the amount of DME or TME per 2 µg of free-living-cell extract. The values obtained for TME and DME were then used as a standard to estimate the amount of each protein in bacteroid extracts by comparing the intensity of the 2 µg of total protein from free-living cells to the standard curves of total bacteroid protein.
|
|
|---|
TME cannot replace the need for DME in symbiotic N2 fixation. In a previous study, it was shown that increasing the TME activity in free-living cells overcame the dme-dependent succinate growth-negative phenotype of S. meliloti strain RmG443 (pckA pod1 dme-2::Tn5) (8). We therefore wished to determine whether increasing the level of TME activity in bacteroids would allow dme mutant strains to fix N2 in nodules. To accomplish this, we placed the tme structural gene under the control of the dme promoter, as this should ensure appropriate tme expression and appropriate TME activity in N2-fixing bacteroids. Since the transcriptional start site for both the tme and dme genes had been determined and since the translational start sites for both genes have been confirmed through the N-terminal sequence of purified DME and TME proteins (26, 39), we were able to interchange the malic enzyme promoters and the structural genes with minimal ambiguity. Oligonucleotide-directed mutagenesis was employed to introduce an SphI site at the ATG start codon for each gene, and the dme promoter region was then cloned upstream of the tme structural gene ATG codon. The dme promoter with the tme structural gene is referred to as pdme-tme, and this construct, in the plasmid pTH433, was inserted into the S. meliloti dme mutant genome via a single crossover recombination as outlined in Fig. 1A (see Materials and Methods).
![]() View larger version (19K): [in a new window] |
FIG. 1. Schematic outlining the integration of the various tme and dme constructs into the S. meliloti genome. A. Integration of the ptme-dme plasmid pTH597 into the tme:: Sp locus. B. Integration of the pdme-tme plasmid pTH433 at the dme::Tn5 locus. C. Integration of the dme c plasmid pTH458 at the dme::Tn5 locus. D. Integration of the pdme-sfcA plasmid pTH513 at the dme::Tn5 locus.
|
|
View this table: [in a new window] |
TABLE 1. S. meliloti strains expressing tme from the dme promoter
|
![]() View larger version (32K): [in a new window] |
FIG. 2. Western blot to detect TME protein present in S. meliloti extracts. Total bacteroid protein was loaded at 2 µg per sample, while 2 µg of free-living-cell extract from S. meliloti wild-type strain Rm1021 was run as a control. Lane 1, Rm1021 (wild-type free-living-cell extract); lane 2, RmG994 (Rm1021 dme-3::Tn5 tme-4:: Sp); lane 3, Rm1021 (wild-type bacteroid extract); lane 4, RmG455 (Rm1021 dme-3::Tn5); lane 5, RmG994 (Rm1021, dme-3::Tn5 tme-4:: Sp); lane 6, RmH897 (RmG994::pdme-tme); lane 7, RmH898 (RmG995::pdme-tme); lane 8, RmH899 (RmG994::pdme-tme); lane 9, RmH900 (RmG995::pdme-tme). Numbers on the left indicate molecular weight markers.
|
The symbiotic N2-fixing abilities and the enzyme activities in both free-living and bacteroid forms of the resulting strains are shown in Table 2. The amounts of DME protein in Western blots of bacteroid extracts as detected with anti-DME antibodies were also determined (Fig. 3). As expected, plants inoculated with dme mutant strains (RmG454 and RmG994) failed to fix N2, as demonstrated by their negligible acetylene reduction (nitrogenase) activity and dry weight values, which were similar to those of uninoculated plants. In contrast, plants inoculated with dme mutant strains that also expressed dme from the tme promoter (RmH979 and RmH980) had 20 to 30% of the acetylene reduction (nitrogenase) activity and 35% of the dry weight of plants inoculated with wild-type Rm1021 (Table 2). These plants were shorter than those inoculated with the wild-type strain but much larger and greener than the uninoculated controls or plants inoculated with the dme mutant strains. Thus, expression of dme from the tme promoter resulted in a sharp reduction in N2 fixation activity in root nodules.
|
View this table: [in a new window] |
TABLE 2. Phenotypes of S. meliloti strains expressing dme from the tme promoter
|
![]() View larger version (50K): [in a new window] |
FIG. 3. Western blot to detect DME in bacteroid extracts. Total bacteroid protein was loaded at 2 µg per sample, while 2 µg of free-living-cell extract from S. meliloti wild-type strain Rm1021 was run as a control. Numbers on the right indicate molecular weight markers. Lane 1, RmH979 (RmG454::ptme-dme); lane 2, RmH981 (RmG995::ptme-dme); lane 3, RmG995 (Rm1021 tme-4:: Sp); lane 4, Rm1021 bacteroid extract (wild type); lane 5, RmH980 (RmG994::ptme-dme); lane 6, RmG994 (Rm1021 dme-3::Tn5 tme-4:: Sp); lane 7, Rm1021 free-living-cell extract (wild type).
|
To increase the level of DME in bacteroids, the dme locus was cloned into the high-copy-number plasmid pBBR5 (20). NAD+-dependent malic enzyme activities in bacteroids from Rm1021 carrying this plasmid were 657 nmol/min/mg protein. However, the dry weights of plants inoculated with this strain were not statistically different from those of plants inoculated with wild-type Rm1021, and we therefore conclude that the level of DME in the wild-type bacteroids is not limiting for N2 fixation. On the other hand, the data from strains in which dme was expressed from the tme promoter show clearly that reducing the level of DME in bacteroids renders the conversion of malate to pyruvate a rate-limiting reaction for N2 fixation. Limiting the rate of pyruvate synthesis is likely to limit the flux of malate through the TCA cycle and hence the generation of ATP and perhaps reductant for nitrogenase. It is also possible that reduced levels of pyruvate could limit alanine dehydrogenase-catalyzed alanine synthesis, and that in turn may reduce N2 fixation (1, 40).
Expression of the 3'-truncated dme gene (dme
c) in S. meliloti dme mutant strains.
The interpretation of the experimental results obtained from manipulations of the TME and DME proteins were complicated by the unusual structure of these proteins. This prompted us to investigate whether the C-terminal PTA-like domain of DME is required for N2 fixation, since DME deletions that lack this region maintain malic enzyme activity (26). Accordingly, we constructed a dme 3'-deletion derivative, referred to as dme
c, which expressed a truncated DME protein lacking the C-terminal 321 amino acids (DME
C). The pTH458 plasmid carrying the dme
c gene and dme promoter was recombined via a single crossover into dme mutant strains as illustrated in Fig. 1C and described in Materials and Methods.
The symbiotic phenotypes of these strains were assessed as described above (Tables 1 and 2). Plants inoculated with dme-1 and dme-2 strains carrying dme
c were Fix+ and had dry weights of 36.4 ± 2.6 mg and 48.3 ± 0.1 mg, respectively, compared to 40.6 ± 3.7 mg for plants inoculated with the wild type strain Rm1021 and 7.1 ± 1.0 mg and 7.4 ± 0.6 mg for plants inoculated with the dme mutant strains. Enzyme assays of bacteroid extracts from dme strains carrying dme
c had NAD+-dependent malic enzyme activity that was comparable to wild-type levels of 71 nmol/min/mg protein. Western blots of these bacteroid extracts showed that strains expressing dme
c produced only the truncated malic enzyme migrating at 49 kDa, compared to the 82 kDa full-length DME protein (Fig. 4). These data verified that the symbiotic phenotype observed was due to the expression of the truncated gene, dme
c, and not to regeneration of an intact dme gene. These results established that the PTA-like C-terminal domain of DME is not required for N2 fixation, and this prompted us to investigate whether a heterologous NAD+ malic enzyme such as that from Escherichia coli could replace the function of DME in N2-fixing bacteroids.
![]() View larger version (29K): [in a new window] |
FIG. 4. Western blot to detect DME and DME C proteins in bacteroid extracts. Total bacteroid protein was loaded at 2 µg per sample. Lane 1, Rm1021 (wild type); lane 2, RmG454 (Rm1021 dme-2::Tn5); lane 3, RmH996 (RmG454::dme c); lane 4, RmH998 (RmG454::dme c); lane 5, RmG456 (Rm1021 dme-1::Tn5); lane 6, RmH999 (RmG456::dme c); lane 7, RmH1000 (RmG456::dme c). Numbers on the left indicate molecular weight markers.
|
Sp) restored the ability of this strain to grow on succinate. To investigate whether sfcA could function symbiotically in root nodules, the pTH513 plasmid was recombined at the dme locus in various dme, dme tme, and tme mutant strains. The symbiotic phenotype of these strains revealed that the E. coli NAD+-dependent malic enzyme restored near-wild-type activity to the dme mutant strains, with plant dry weights varying from 65 to 84% of that of the wild-type-inoculated plants (RmK215, RmK216, RmK217, and Rm1021) (Table 3). Student's t test showed no statistical significant difference between dry weight values for the wild-type-inoculated and the RmK215-, RmK216-, and RmK217-inoculated plants. Enzyme assays conducted with dme mutant bacteroids expressing sfcA revealed approximately half (44 to 59%) of the NAD+-dependent malic enzyme activity present in wild-type bacteroids (Table 3). Native PAGE gels stained for NAD+-dependent malic enzyme activity revealed that the scfA-encoded protein was present in the RmK215, RmK216, and RmK217 bacteroid extracts and that, as expected, no DME was present (Fig. 5. ) These data demonstrate that the E. coli NAD+-dependent malic enzyme is capable of restoring wild-type N2-fixing activity to S. meliloti dme mutant strains and confirm that the DME C-terminal PTA-like domain is not required for N2 fixation. |
View this table: [in a new window] |
TABLE 3. Phenotypes of S. meliloti strains expressing the sfcA gene under the control of the dme promoter
|
![]() View larger version (31K): [in a new window] |
FIG. 5. Nondenaturing PAGE to show NAD+-dependent malic enzyme in bacteroid extracts of S. meliloti expressing sfcA. Protein was loaded at 30 µg per sample, and the gel was stained to detect NAD+-dependent malic enzyme activity. Lane 1, Rm1021 (wild type); lane 2, RmK219 (Rm1021::pdme-sfcA); lane 3, RmG995 (Rm1021 tme-4:: Sp); lane 4, RmK218 (RmG995::pdme-sfcA); lane 5, RmG455 (Rm1021 dme-3::Tn5); lane 6, RmK215 (RmG455::pdme-sfcA); lane 7, RmG456 (Rm1021 dme-1::Tn5); lane 8, RmK216 (RmG456::pdme-sfcA); lane 9, RmG994 (Rm1021 dme-3::Tn5 tme-4:: Sp); lane 10, RmK217 (RmG994::pdme-sfcA).
|
|
|
|---|
The observation that low levels of NAD+ malic enzyme in bacteroids supported significant symbiotic N2 fixation is in contrast to the finding that increasing the levels of NADP+ malic enzyme in bacteroids failed to support detectable N2-fixing activity in dme mutants. This result is more striking given that the NADP+ malic enzyme can function in place of DME in allowing a S. meliloti pckA1 pod-1 dme-1::Tn5 tme-4::
Sp mutant to grow on succinate as a carbon source. The ability of the C-terminal-deletion derivative of DME together with the ability of the E. coli NAD+ malic enzyme to restore wild-type N2-fixing activity to S. meliloti dme mutants clearly demonstrates that the PTA-like domain of DME is not required for N2 fixation. Moreover, this strongly suggests that the failure of TME to replace DME in N2-fixing bacteroids is unrelated to differences in their PTA-like C-terminal domains.
DME has Kms of 9.4 mM for L-malate and 89 µM for NAD+, while TME has Kms for malate and NADP+ of 12.5 mM and 33 µM, respectively (39). The TME Vmax of 53 µmol/min/mg protein is close to the DME Vmax of 60 µmol/min/mg protein. Overall, the kinetic parameters for DME and TME are similar, and therefore it appears unlikely that these account for the different symbiotic properties of the two enzymes. However, unlike the NADP+-dependent malic enzyme, the S. meliloti NAD+ malic enzyme is allosterically regulated, with acetyl-CoA inhibiting and succinate and fumarate activating activity (39). Since kinetic results in our laboratory have revealed that DME
C is no longer allosterically regulated (unpublished results), and since DME
C functions in place of DME in nodules, we can conclude that the allosteric nature of DME is not essential to its function in bacteroids.
The E. coli NAD+ malic enzyme was characterized by several groups, and Km values for the substrate L-malate have been reported in the range from 0.1 to 0.4 mM, while the Km for the NAD+ cofactor has been estimated to be 23 and 55 µM (17, 33, 36, 41). As in the case of DME, the E. coli NAD+ malic enzyme is allosterically regulated, with inhibition of activity by acetyl-CoA and activation by malate (9, 28, 32, 39). Thus, except for a higher affinity for L-malate, the E. coli NAD+ malic enzyme compares favorably with DME, and it is not surprising that the E. coli enzyme can function in place of DME. However, as the two enzymes share little amino acid similarity, it would appear that the ability of the E. coli enzyme to function in bacteroids simply reflects its ability to catalyze the NAD+-dependent conversion of malate to pyruvate.
Given that neither differences in the catalytic rate nor the affinity for L-malate is sufficient to account for the failure of TME to act in place of DME in N2-fixing bacteroids, we hypothesize that there is a high ratio of NADPH+ + H+/NADP+ in bacteroids and that this prevents TME from functioning in nodules. The ratios of NAD(P)H+ + H+/NAD(P)+ in bacteroids from alfalfa nodules have not been determined; however, the levels in soybean bacteroids have been reported in two studies. Tezuka and Murayama (38) reported NAD/NADH and NADP/NADPH ratios for soybean bacteroids of 5.56 and 3.26, respectively. These values are higher than those reported by Tajima and Kouzai (37), which were 2.17 and 0.37, respectively. Possible reasons for the different results, such as methods used in the extraction and assay of pyridine nucleotides in bacteroids, have been discussed (38). Nevertheless, the very different values for the NADP/NADPH ratios (3.26 and 0.37) do not allow us to draw inferences; interpretations are also complicated by the fact that the properties of the Bradyrhizobium japonicum NAD+ and NADP+ malic enzymes appear to differ from those of the S. meliloti DME and TME enzymes, and it has been suggested that the physiological roles of the enzymes are different in S. meliloti and B. japonicum (4, 5).
The hypothesis that there is a high ratio of NADPH+ + H+ to NADP+ in bacteroids is difficult to reconcile with the observations that S. meliloti isocitrate dehydrogenase (Idh) is an NADP+-dependent enzyme and that mutants deficient for this activity are unable to support symbiotic nitrogen fixation, as determined by McDermott and Kahn (25). Isocitrate dehydrogenase has been purified from S. meliloti and has a Km of 15 µM for NADP+ (3), which is half that of TME (39). This low Km may be a reason why isocitrate dehydrogenase is capable of functioning under conditions of restricted NADP+ while TME cannot. Interestingly, an NAD+-dependent isocitrate dehydrogenase has been reported for rhizobia infecting Lotus pedunculatus; however, this does not appear to be a widespread phenomenon among prokaryotes (27). To directly address the issue of cofactor dependence, we wish to alter the cofactor specificity of TME from NADP+ to NAD+ to determine whether such an enzyme would support N2 fixation by a dme mutant strain.
Microbial genome sequences have revealed the presence of malic enzyme-like proteins, presumably the NAD+ and NADP+ enzymes, in many bacteria. In E. coli, the presence of two enzymes has been known for some time; however, the distinct roles played by these enzymes have not been clearly defined (17, 28, 33, 41). In Corynebacterium glutamicum the malE-encoded NADP-dependent malic enzyme plays an important role in routing carbon flux between glycolysis and gluconeogenesis (15, 29). Aymerich and colleagues recently identified and characterized four malic enzyme isoforms from Bacillus subtilis (6, 23). Disruption of the ytsJ gene resulted in a markedly reduced growth on malate despite the presence of the other enzymes. YtsJ is the sole NADP-dependent malic enzyme, and the mutant phenotype showed that it plays a role distinct from those of the other malic enzymes in B. subtilis. Paradoxically, while overexpression of the E. coli NADP-dependent malic enzyme in B. subtilis did not suppress the malate growth phenotype of the ytsJ mutant, overexpression of the E. coli transdehydrogenase gene (udhA) did partially suppress this phenotype. Those authors concluded that YtsJ may play an additional physiological role beyond the conversion of malate to pyruvate. It is clear that much remains to be established regarding the physiological roles of malic enzyme, and accordingly the analysis of the Sinorhizobium DME and TME enzymes and the establishment of their roles should be informative with respect to general microbial metabolism.
C. We thank Punita Anjea and Rahat Zaheer for critical reading of the manuscript. T.M.F. gratefully acknowledges the financial support from the Natural Sciences and Engineering Research Council of Canada.
Published ahead of print on 27 October 2006. ![]()
Supplemental material for this article may be found at http://jb.asm.org/. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»